Oruka Therapeutics, Inc. ORKA Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $46.94M-23.8% | $61.58M+64.5% | $37.43M-11.8% | $42.45M-20.5% | ||
| $142.54M+689% | $18.07M— | —— | —— | ||
| $343.86M-8.8% | $376.87M+903% | $37.59M-12.0% | $42.7M-21.5% | ||
| $288K+77.8% | $162K+1,520% | $10K-60.0% | $25K-47.9% | ||
| $2.94M+99.3% | $1.48M— | —— | —— | ||
| $488.62M+23.4% | $396.02M+946% | $37.86M-12.1% | $43.09M-21.6% | ||
| $15.37M+17.9% | $13.04M+1,948% | $637K-43.7% | $1.13M-67.6% | ||
| $16.69M+20.9% | $13.8M+1,541% | $841K-40.4% | $1.41M-63.6% | ||
| 545M0.0% | 545M+3,892,757% | 14K0.0% | 14K0.0% | ||
| -$189.16M-126% | -$83.72M+55.6% | -$188.74M-2.9% | -$183.4M-5.7% | ||
| $471.93M+23.5% | $382.22M+932% | $37.02M-11.2% | $41.67M-18.4% | ||
| $488.62M+23.4% | $396.02M+946% | $37.86M-12.1% | $43.09M-21.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Oruka Therapeutics, Inc.'s total assets?
- Oruka Therapeutics, Inc. (ORKA) holds $504.5M in total assets, up 33.8% year over year.
- How much debt does Oruka Therapeutics, Inc. have?
- Oruka Therapeutics, Inc. carries $1.8M in total debt against $486.7M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Oruka Therapeutics, Inc. have?
- Oruka Therapeutics, Inc. holds $49.5M in cash and equivalents.
- Can Oruka Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 23.76 — current assets exceed current liabilities.
- Where does Oruka Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Oruka Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.